#073: “Haciendo Lo Invisible, Visible”. Crys’s Journey of Invisible Battles and Visible Triumphs as Latina with MS in the US
Today I’m talking to Crys about her life with multiple sclerosis as a first generation Latina. Crys was diagnosed at age eleven and experienced her most severe episode at age 13 when she was paralyzed from the neck down. She recovered from this episode thanks to the devoted support of her family, especially her mother. […]
#072: Natalizumab (Tysabri, Tyruko) for active relapsing remitting MS
Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
#070: Teriflunomide (Aubagio) for relapsing remitting MS
Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
#068: Interferon-beta (Avonex, Betaferon, Extavia, Plegridy, Rebif, …) for CIS, RRMS & SPMS
Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
#065: Glatiramer Acetate (Copaxone) for relapsing remitting multiple sclerosis
Glatiramer Acetate belongs to the oldest immunotherapies for relapsing remitting multiple sclerosis and is used for mild or moderate courses.
#062: Dimethyl fumarate (Tecfidera) & Diroximel fumarate (Vumerity) for relapsing remitting MS
Tecfidera and Vumerity, the fumarates for mild or moderate MS kick-off the informative series about immunotherapy for multiple sclerosis.
#038: Brain health. Time matters in multiple sclerosis – Summary of the report
Facts in a nutshell! The MS Brain Health Organization’s report on a healthy brain explains why time is important in multiple sclerosis.
#008: Different types of treatment and prevention for MS
Treatment options include relapse management, disease-modifying therapy, symptom management, complementary therapy and a healthy lifestyle.
#007: The types of MS – from prodromal phase to progressive course
Multiple sclerosis (MS) is one disease but it is defined in different types depending on the prominent aspect at the moment of treatement.
#006: Interview with Tania Pilz about the international MS-Community Austria and more
Tania Pilz talks about her experiences with MS and the international MS-Community Austria which she founded for more inclusion.
